Utility of QuantiFERON-TB In-Tube Test for Differentiating Active Tuberculosis from Latent Tuberculosis Infection in an Intermediate Burden Country
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : The aim of the present study was to assess the contribution of a QuantiFERON-TB Gold In-Tube test (QFT-IT) in differentiating active tuberculosis (TB) from latent tuberculosis infection (LTBI) by quantifying interferon-γ levels. Materials and Methods : We retrospectively reviewed clinical records of 314 patients older than 15 years who had performed QFT-IT between July 2006 and August 2007 at a tertiary care teaching hospital. Results : Subjects with active TB (n=81, culture confirmed active TB in 40 subjects) and LTBI (n=76) were included. Mean±SD IFN-γ levels were 4.96±3.98 IU/mL (range -0.08-10) for all subjects with active TB, 4.54±4.05 IU/mL (range -0.08-10) for culture confirmed active TB, and 4.11±3.57 IU/mL (range 0.35-10) for subjects with LTBI. The quantitative results of QFT-IT on IFN-γ levels between all the subjects with active TB and those with LTBI were not statistically significant (P=0.16). The result was similar when compared between those with culture confirmed active TB and those with LTBI, showing little statistical significance (P=0.554). Conclusion : The production of IFN-γ measured by QFT-IT showed no correlation between its level and the activity of Mycobacterium tuberculosis infection. These results suggest that measuring IFN-γ using QFT-IT might not be useful for distinguishing active TB from LTBI.
Abstract
Background : The aim of the present study was to assess the contribution of a QuantiFERON-TB Gold In-Tube test (QFT-IT) in differentiating active tuberculosis (TB) from latent tuberculosis infection (LTBI) by quantifying interferon-γ levels. Materials and Methods : We retrospectively reviewed clinical records of 314 patients older than 15 years who had performed QFT-IT between July 2006 and August 2007 at a tertiary care teaching hospital. Results : Subjects with active TB (n=81, culture confirmed active TB in 40 subjects) and LTBI (n=76) were included. Mean±SD IFN-γ levels were 4.96±3.98 IU/mL (range -0.08-10) for all subjects with active TB, 4.54±4.05 IU/mL (range -0.08-10) for culture confirmed active TB, and 4.11±3.57 IU/mL (range 0.35-10) for subjects with LTBI. The quantitative results of QFT-IT on IFN-γ levels between all the subjects with active TB and those with LTBI were not statistically significant (P=0.16). The result was similar when compared between those with culture confirmed active TB and those with LTBI, showing little statistical significance (P=0.554). Conclusion : The production of IFN-γ measured by QFT-IT showed no correlation between its level and the activity of Mycobacterium tuberculosis infection. These results suggest that measuring IFN-γ using QFT-IT might not be useful for distinguishing active TB from LTBI.
참고문헌 (20)
- Richeldi L, "An update on the diagnosis of tuberculosis infection", Am J Respir Crit Care Med, 174, pp.736~742 (2006)
- Diel R, "Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test", Eur Respir J, 28, pp.16~23 (2006)
- Brock I, "Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts", Am J Respir Crit Care Med, 170, pp.65~69 (2004)
- Ewer K, "Comparison of T- cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak", Lancet, 361, pp.1168~1173 (2003)
- Lalvani A, "Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells", Lancet, 357, pp.2017~2021 (2001)
- Richeldi L, "Early diagnosis of subclinical multidrug-resistant tuberculosis", Ann Intern Med, 140, pp.709~713 (2004)
- Lalvani A, "Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians", J Infect Dis, 183, pp.469~477 (2001)
- Mori T, "Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens", Am J Respir Crit Care Med, 170, pp.59~64 (2004)
- Kang YA, "Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country", JAMA, 293, pp.2756~2761 (2005)
- Mazurek GH, "Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States", MMWR Recomm Rep, 54, pp.49~55 (2005)
- Meier T, "Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice", Eur J Clin Microbiol Infect Dis, 24, pp.529~536 (2005)
- Liebeschuetz S, "Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study", Lancet, 364, pp.2196~2203 (2004)
- Lee JY, "Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection", Eur Respir J, 28, pp.24~30 (2006)
- Ravn P, "Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis", Clin Diagn Lab Immunol, 12, pp.491~496 (2005)
- Goletti D, "Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay", Clin Diagn Lab Immunol, 12, pp.1311~1316 (2005)
- Goletti D, "Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study", Clin Microbiol Infect, 12, pp.544~550 (2006)
- Janssens JP, "Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis", Eur Respir J, 30, pp.722~728 (2007)
- QuantiFERON-TB Gold (In-Tube Method) package insert, "Cellestis Ltd", ~, pp.Cat. no. 0599 0201 (2004)
- WHO REPORT 2007; Global Tuberculosis Control, Surveillance, Planning, Financing, "WHO", Financing, ~ (2007)
- Kang YA, "Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme- linked immunospot assay in the diagnosis of active pulmonary tuberculosis", Chest, 132, pp.959~965 (2007)